IRCT201312263930N30已完成2 期
The efficacy of pramipixole as an adjuvant treatment with citalopram for treating major depressive disorder, a randomized placebo controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •patients aged 18 to 65 years old, major depressive disorder using DSM-IV diagnostic criteria.
- •Exclusion criteria: serious uncontrolled medical conditions, bipolar mood disorder.
排除标准
- 未提供
研究者
相似试验
尚未招募
早期 1 期
Pramipexole and relapse of stimulants abuseIRCT20190315043060N1Kerman University of Medical Sciences100
已完成
2 期
Effectiveness of pregabalin on chronic nonbacterial prostatitisChronic nonbacterial prostatitis.Other inflammatory diseases of prostateIRCT2016022225507N2Vice Chancellor for Research of Arak University of Medical Sciences288
已完成
2 期
use of unani medicine in thyroid problemCTRI/2018/03/012289ational Institute of Unani medicine40
招募中
1 期
Adjuvant treatment with Pramipexole for anhedonia symptoms in depression - PRIME-PRAXOMajor depressionMedDRA version: 20.0Level: PTClassification code: 10002511Term: Anhedonia Class: 100000004873CTIS2024-512495-35-00Region Skane140
尚未招募
3 期
Probiotics in childhood viral encephalitisCTRI/2011/11/002127India Council of Medical Research380